Brown, Todd T <br/><br/>
Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  Aug 2009 
 - 554-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-4135 
<br/><br/><label>Standard No.: </label>10.1097/QAI.0b013e3181adce44  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorptiometry, Photon<br/>Adult<br/>Alkynes<br/>Anti-HIV Agents--adverse effects<br/>Benzoxazines--adverse effects<br/>Bone Density--drug effects<br/>Cyclopropanes<br/>Female<br/>HIV Infections--complications<br/>Humans<br/>Inflammation Mediators--blood<br/>Lamivudine--adverse effects<br/>Lopinavir<br/>Male<br/>Middle Aged<br/>Osteoporosis--chemically induced<br/>Prospective Studies<br/>Pyrimidinones--adverse effects<br/>Receptors, Tumor Necrosis Factor, Type I--blood<br/>Receptors, Tumor Necrosis Factor, Type II--blood<br/>Risk Factors<br/>Ritonavir--adverse effects<br/>Zidovudine--adverse effects